VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CMECME Group Inc.
$274.07$99.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCMECash Flow

CME Group Inc. (CME) Cash Flow Statement

26Y historyFree accessUpdated daily

Operating cash flow averaged $1.1B quarterly, consistently exceeding net income, with dividends totaling $2.7B in 2026Q1, but buybacks remained modest at $698M in Q2, highlighting a dividend-focused capital return strategy.

Income StatementBalance SheetCash FlowRatios

CME Cash Flow Statement

Annual statement

CME Cash Flow Statement

CME Group Inc. (CME) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash from Operations4.31B4.28B3.69B3.45B3.06B2.4B2.72B2.67B2.44B1.84B1.72B1.52B1.29B1.28B1.22B1.35B1.36B1.08B1.2B814.37M471.7M391.59M328.81M191.15M141.14M120.57M32.97M
Operating CF Growth %10.23%15.89%6.85%13.02%27.21%-11.53%1.6%9.51%32.62%7.25%13.24%17.34%0.85%5.24%-9.62%-0.74%25.23%-9.53%47.01%72.65%20.46%19.1%72.02%35.43%17.06%265.7%-
Net Income4.27B4.07B3.53B3.23B2.69B2.64B2.11B2.12B1.96B4.06B1.53B1.25B1.13B978.1M906.7M1.81B952.1M825.8M715.49M658.53M407.35M306.86M219.56M122.13M94.07M68.3M-5.91M
Depreciation & Amortization332.5M330.9M336.8M352.6M362.6M385.4M464.4M473.3M248.7M208.5M225.3M228.6M233.2M238.1M253.1M260.5M258M251.4M238.37M142.69M75.32M68.22M56.93M53.02M48.51M37.64M33.49M
Deferred Taxes6.4M-6.1M-66.4M-75M-23.2M34.8M-41.6M-3.7M114.3M-2.36B-83M63.3M78.9M-6M82.2M-658.7M22.3M-56.9M-115.11M-50.58M-24.85M-3.25M4.26M3.31M-5.64M-8.88M811K
Other Non-Cash Items-428.6M-314.4M-3.6M-37.7M36.5M-568.1M31.2M48.9M-32.1M-115M-23.3M70.8M-2.3M31.2M-84.6M20.8M44.4M61.2M361.78M36.86M6.92M59.05M65.48M7.4M4.04M17.22M7.31M
Working Capital Changes12.2M99.7M-191.6M-95.2M-95.2M-161.8M59.2M-34.6M49.7M-16.7M-3.3M-155.2M-200.1M-15.3M-2M-142M38.7M-31.8M-34.88M4.03M-9.4M-39.29M-17.42M5.29M163K6.29M-2.73M
Cash from Investing1.48B1.5B-82.6M20.9M-489.8M58.4M-175.5M-152.6M-1.89B179.9M53.7M17.9M-199.1M190.5M-206M-153.6M-108.4M544.8M-3.75B-78.64M-85.86M-82.33M-125.84M-327.05M34.35M-78.22M-12.95M
Purchase of Investments-4.4M-6M-4.5M-4.1M-4.4M-7.8M-11.1M-15.4M-10M-3M-45.9M-35.3M-38.3M-36.6M-32.5M-10.2M-10.2M-159.9M-367.55M-129.13M-44.77M-70.06M-120.18M-256.42M-43.96M-286.54M-43.12M
Sale/Maturity of Investments5.1M7.9M6M5.9M6.3M9.4M12.3M18.8M11.8M266.1M191.7M184.1M37.5M164.3M5.1M11.3M59.1M865.7M375.2M203.8M73.67M75.23M68.33M0137.72M240M59.52M
Net Investment Activity700K1.9M1.5M1.8M1.9M1.6M1.2M3.4M1.8M263.1M145.8M148.8M-800K127.7M-27.4M1.1M48.9M705.8M7.65M74.68M28.9M5.17M-51.85M-256.42M93.77M-46.54M16.4M
Acquisitions1.58B1.58B9.9M95.5M-402M144.7M20.8M89.6M-1.77B-1.3M-300K-16.7M-59.3M-4M-188.3M172.2M-37M0-3.48B116.01M-20.23M0000011.17M
Other Investing-6.8M000039.3M000261.8M145.5M7M1.7M192.4M151.5M-154.7M39.7M-3.1M-80.58M-105.68M-6.71M-1.87M-6.49M-7.62M-3.07M-15.38M-29.35M
Cash from Financing10.32B56.51B5.08B-48.34B-25.38B69.91B-2.46B-2.34B-1.08B-1.99B-1.59B-1.21B-2.2B-606M-448.4M-1.01B-653.4M-1.67B2B-859.93M-27.22M-55.93M-30.53M-18.23M94.67M-3.9M-3.61M
Dividends Paid-4.08B-3.93B-3.58B-3.24B-2.63B-2.19B-2.11B-1.7B-2.15B-1.99B-1.79B-1.34B-1.5B-599.1M-1.22B-372.8M-912.8M-305.6M-615.19M-151.58M-87.54M-63.26M-35.07M-20.63M-17.29M00
Share Repurchases-1.52B-266.1M-33M-21.4M-24.8M0-41.4M-36.8M0000000-220.4M-575.3M-27M-224.03M-949.34M0000000
Stock Issued00000965M036.8M398.4M36.7M51.8M64M0000607.1M011.37M40.41M16.43M7.33M6.05M7.88M117.46M00
Net Stock Activity-1.52B-266.1M-33M-21.4M-24.8M965M-41.4M0398.4M36.7M51.8M64M000-220.4M31.8M-27M-212.66M-908.93M16.43M7.33M6.05M7.88M117.46M00
Debt Issuance (Net)-1000K-1000K0-1000K-1000K0-1000K-1000K1000K001000K-1000K-1000K1000K-1000K1000K-1000K1000K1000K01000K-1000K-1000K-1000K-1000K-1000K
Other Financing15.92B60.72B8.69B-45.07B-22.71B71.13B-2.2M53.6M-447.9M-28.5M11.7M83.2M-2.4M-79.3M6.1M8.1M19.5M-432.5M-85.65M37.73M43.88M-7.33M00000
Net Change in Cash16.11B62.29B8.68B-44.86B-22.82B72.37B81.9M179.4M-528.8M35M176M326.5M-1.1B865M562.4M187.1M594.6M-37.3M-547.42M-124.19M358.61M253.33M172.44M-154.14M270.16M38.45M16.41M
Exchange Rate Effect000000000000000000000000000
Cash at Beginning167.43B101.79B93.11B137.97B160.79B88.42B1.56B1.38B1.91B1.87B1.69B1.37B2.47B1.6B1.04B855.2M260.6M297.9M845.31M969.5M610.89M357.56M185.12M339.26M69.1M30.66M14.25M
Cash at End160.26B164.08B101.79B93.11B137.97B160.79B1.64B1.56B1.38B1.9B1.87B1.69B1.37B2.47B1.6B1.04B855.2M260.6M297.89M845.31M969.5M610.89M357.56M185.12M339.26M69.1M30.66M
Interest Paid140.8M135.6M129.9M129.9M133.2M133.3M133.3M146.3M108.3M84.8M84.8M89.1M111.4M133.4M110.6M111.9M104.9M90.8M21.1M00000000
Income Taxes Paid1.27B1.16B1.2B1.11B973.4M755M652.7M591.2M577.4M762.8M706.7M716.6M641.5M612.2M624.4M816.1M765.9M629.7M665.4M00000000
Free Cash Flow4.21B4.19B3.6B3.38B2.97B2.28B2.52B2.43B2.32B1.76B1.62B1.4B1.15B1.15B1.07B1.17B1.2B925.2M997.1M650.73M383.89M305.97M261.31M128.13M84.8M104.27M21.8M
FCF Growth %2.56%16.6%6.49%13.86%30.38%-9.65%3.75%4.44%32.16%8.27%15.92%21.76%-0.36%7.43%-8.44%-1.86%29.31%-7.21%53.23%69.51%25.47%17.09%103.94%51.11%-18.67%378.31%-

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

FMX competition and EPS miss

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Earnings Retention Powers Capital Base

CME's operating cash flow averaged $1.1B quarterly over the last year, consistently exceeding net income, indicating strong earnings retention and organic capital generation, as per financial statements.

The OCF/NI ratio has remained above 1.0 in most quarters, with 2026Q1 at 1.09 and 2025Q3 at 1.07, suggesting that non-cash items like depreciation and deferred taxes are boosting cash generation. This retained cash supports the company's ability to fund growth initiatives and maintain a fortress balance sheet without relying on external debt, as evidenced by zero long-term debt issuances in the period. The consistent cash generation appears to underpin management's capacity to return capital to shareholders while preserving regulatory flexibility.

Minimal Securities Portfolio Activity

Investment securities purchases and sales were negligible, averaging under $2M per quarter, indicating a stable, low-turnover portfolio that does not materially impact cash flows, based on reported figures.

The near-zero investment activity suggests CME holds securities primarily for liquidity and regulatory purposes rather than yield enhancement, with no significant reinvestment or duration shifts observed. This aligns with the company's capital-light model, where cash is predominantly generated from operations and returned to shareholders rather than deployed into investment portfolios. Investors should monitor whether this inactivity persists, as it implies limited interest rate sensitivity from the securities book.

Loan Book Cash Flows Minimal

CME's loan loss provisions spiked to $568.3M in 2026Q2, a 216% increase from Q1, yet loan-related cash flows remain immaterial, suggesting the provision reflects clearing member risk rather than traditional lending, as disclosed.

The provision jump appears tied to potential default fund or collateral volatility, not loan originations, given the absence of loan growth in the cash flow statement. This indicates that CME's credit exposure is concentrated in clearing activities, where margin requirements and default funds are adjusted based on market conditions. The elevated provision may signal increased counterparty risk, but the lack of actual loan cash flows suggests it is a reserve build rather than realized losses, warranting monitoring of clearing member health.

Variable Dividend Drives Capital Returns

Dividends totaled $2.7B in 2026Q1, reflecting the annual variable dividend, while buybacks remained modest at $698M in Q2, indicating a shareholder return strategy weighted toward dividends, as per financial statements.

The quarterly dividend of approximately $455M is consistent, but the variable dividend in Q1 creates significant cash outflow volatility, with total dividends in 2026Q1 exceeding operating cash flow of $1.3B, suggesting reliance on accumulated cash reserves. Buybacks are opportunistic and small, averaging under $300M per quarter, which may indicate management's preference for returning cash via dividends rather than repurchases, possibly to maintain flexibility. The sustainability of the variable dividend appears supported by robust OCF, but the Q1 payout ratio of over 200% of OCF highlights the need for strong cash generation to maintain this policy.

Deposit Flows Not Applicable

CME does not report traditional deposit flows, as its business model relies on clearing member collateral rather than customer deposits, making deposit beta analysis irrelevant, based on reported data.

The absence of deposit-related cash flows underscores CME's unique structure as an exchange and clearinghouse, where performance bonds and deposits are held on behalf of members but not classified as deposits. Interest income on these collateral balances may fluctuate with rates, but the cash flow statement does not isolate these flows, limiting direct analysis. Investors should instead focus on clearing volume and margin requirements as the primary drivers of cash generation.

Cash Flow Hides Collateral Risks

The cash flow statement obscures the scale of performance bond deposits and potential default fund exposures, which could create hidden liquidity demands if clearing members face stress, as per financial disclosures.

While operating cash flow appears robust, the statement does not reflect the potential for large collateral outflows if clearing members default or if margin requirements increase sharply, as seen in the Q2 provision spike. The $568.3M provision may be a precursor to actual cash outflows if losses materialize, but the timing and magnitude remain uncertain. Additionally, the Google Cloud partnership could shift capital expenditures to operating expenses, potentially reducing future OCF, though this is not yet visible in the data. Investors should monitor clearing member creditworthiness and any off-balance-sheet commitments that could strain liquidity.

CME — Frequently Asked Questions

Quick answers to the most common questions about buying CME stock.

How much cash does CME Group Inc. (CME) generate from operations?

CME Group Inc. (CME) generated $4.28B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is CME Group Inc.'s free cash flow?

CME Group Inc. (CME) generated $4.19B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is CME Group Inc.'s capital expenditure (CapEx)?

CME Group Inc. (CME) spent $83.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does CME Group Inc. distribute cash to shareholders?

In 2025, CME Group Inc. (CME) returned $3.93B to shareholders via cash dividends and spent $266.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.